ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Cancer Cells
Teruaki Takasaki(Osaka University of Pharmaceutical Sciences), Reiko Sugiura(Kindai University)
Cited by 3
Related Papers
Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target
|Oncotarget|2021|17
Down‐regulation of dual‐specificity phosphatase 6, a negative regulator of oncogenic ERK signaling, by ACA‐28 induces apoptosis in NIH/3T3 cells overexpressing HER2/ErbB2
|Genes to Cells|2020|9
Rapamycin Abrogates Aggregation of Human α‐Synuclein Expressed in Fission Yeast via an Autophagy‐Independent Mechanism
|Genes to Cells|2024|5
Fission Yeast PUF Proteins Puf3 and Puf4 Are Novel Regulators of PI4P5K Signaling
|Biological and Pharmaceutical Bulletin|2023|1